The latest update for our Prime Time portfolio is a provider of high-performance glass for LCD televisions, computer monitors, and other information display applications, notes Charles Mizrahi, editor of Hidden Values Alert.
We like the diversification behind Corning (GLW). The company gets 36% of its revenues from Display technologies, 27% from Telecommunications, 12% from Environmental Technology, 17% from Specialty Materials (tablets/mobiles phones), and 8% from Life Sciences.
This diversification reduces the company's exposure to a specific industry, smoothing out potential bumps in the road to a particular segment.
GLW spent more than $700 million on R&D in the past 12 months (about 9% of revenue). The company continues to find applications for its glass technology.
The company can employ its proprietary technology in growth drivers such as the smartwatch and smart television markets, as well as windshields or marker boards.
GLW has more than $10.6 billion of cash and investments on its balance sheet. The company has very little short-term debt ($23 million).
Hot Growth Companies To Watch In Right Now: Magellan Health Services Inc.(MGLN)
Magellan Health Services, Inc. engages in the specialty managed healthcare business in the United States. The company, through its contracted network of third-party treatment providers, offers managed behavioral healthcare services, including outpatient programs, such as counseling or therapy; intermediate care programs comprising intensive outpatient programs and partial hospitalization services; and inpatient treatment and crisis intervention services. It also provides radiology benefits management services, such as the delivery of diagnostic imaging and other therapeutic services through contracts with health plans and insurance companies, and governmental agencies. In addition, the company offers specialty pharmaceutical management services, including contracting and formulary optimization programs; specialty pharmaceutical dispensing operations; and medical pharmacy management programs. Its specialty pharmaceutical management services are provided under contracts with health plans, insurance companies, employers, and governmental agencies to manage specialty drugs used in the treatment of conditions, such as cancer, multiple sclerosis, hemophilia, infertility, rheumatoid arthritis, chronic forms of hepatitis, and other diseases. Further, the company provides Medicaid administration services comprising pharmacy point-of-sale claims processing systems and administration, drug utilization review, clinical prior authorization, utilization and formulary management services, preferred drug list programs, maximum allowable cost programs, and drug rebate program services under contracts with health plans and public sector healthcare clients for Medicaid and other program recipients. It serves health plans, insurance companies, employers, labor unions, and various governmental agencies. Magellan Health Services, Inc. was founded in 1969 and is based in Avon, Connecticut.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Magellan Health Services (Nasdaq: MGLN ) , whose recent revenue and earnings are plotted below. - [By Lauren Pollock]
Magellan Health Services(MGLN), which manages public-sector pharmacy benefits programs and other health-care services, offered a preliminary earnings forecast for next year that badly missed Wall Street expectations as share repurchases and the effect of the Affordable Care Act tax are seen hurting the bottom line, while its revenue estimate was stronger than expected.
- [By Susan J. Aluise]
Although Medicaid has far slimmer margins than other business lines, MOH has the expertise to gain volume as enrollees grow. It also has a strong Medicaid franchise in two key states: California and Washington. MOH has a price to earnings growth (PEG) ratio of only 0.8, suggesting that the stock could be undervalued. It also has a forward P/E of 14, lower than many other healthcare stocks.
Healthcare Stocks: Magellan Health Services (MGLN)Magellan Health Services (MGLN) recently rebranded its business lines into three distinct units. The company’s behavior health affiliates, along with integrated health business Magellan Complete Care, are branded under the Magellan Healthcare business. Magellan Rx Management focuses on Magellan’s pharmacy business. And the specialty solutions business is now branded under NIA Magellan.
Top Life Sciences Stocks To Own For 2014: China Nepstar Chain Drugstore Ltd (NPD)
China Nepstar Chain Drugstore Ltd. operates retail drugstores in the People?s Republic of China. The company?s drugstores provide pharmacy services and other merchandise, including prescription drugs; over-the-counter drugs; nutritional supplements, such as healthcare supplements, vitamins, minerals, and dietary products; herbal products, including drinkable herbal remedies and packages of assorted herbs for making soup; and private label products. Its stores also offer personal care products, such as skin care, hair care, and beauty products; family care products, including portable medical devices for family use, birth control products, and early pregnancy test products; and convenience products, such as soft drinks, packaged snacks, other consumables, cleaning agents, and stationeries, as well as seasonal and promotional items. The company operates its stores under the China Nepstar brand name. As of December 31, 2009, its store network comprised 2,479 retail drugstores located in approximately 71 cities in Guangdong, Jiangsu, Zhejiang, Liaoning, Shandong, Hunan, Fujian, Sichuan, and Hubei provinces, as well as in Shanghai, Tianjin, and Beijing municipalities of the People?s Republic of China. The company was founded in 1995 and is headquartered in Shenzhen, the People?s Republic of China.
Advisors' Opinion:- [By Garrett Cook]
Non-cyclical consumer goods & services shares dropped around 0.20 percent in today’s trading. Top decliners in the sector included K12 (NYSE: LRN), China Nepstar Chain Drugstore (NYSE: NPD), and Du Pont (NYSE: DD).
Top Life Sciences Stocks To Own For 2014: Foot Locker Inc (FL)
Foot Locker, Inc., incorporated on April 7, 1989, is a global retailer of shoes and apparel, operating 3,335 primarily mall-based stores in the United States, Canada, Europe, Australia, and New Zealand as of February 2, 2013. The Company operates in two segments: Athletic Stores and Direct-to-Customers. The Athletic Stores segment is an athletic footwear and apparel retailer whose formats include Foot Locker, Lady Foot Locker, Kids Foot Locker, Champs Sports, Footaction, and CCS. The Direct-to-Customers segment includes Footlocker.com, Inc. and other affiliates, including Eastbay, Inc. and CCS, which sell to customers through Internet websites, mobile devices, and catalogs. In September 2013, the Company acquired Runners Point Warenhandels GmbH (Runners) from Hannover Finanz GmbH.
Athletic Stores
Foot Locker is a global athletic footwear and apparel retailer. Its stores offer the products manufactured primarily by the athletic brands. Foot Locker offers products for a variety of activities, including basketball, running, and training. Additionally, the Company operates 65 House of Hoops, primarily a shop-in-shop concept, which sells basketball inspired products. Foot Locker�� 1,883 stores are located in 23 countries, including 1,072 in the United States, Puerto Rico, United States Virgin Islands, and Guam, 129 in Canada, 590 in Europe, and a combined 92 in Australia and New Zealand. The domestic stores have an average of 2,300 selling square feet and the international stores have an average of 1,500 selling square feet. Lady Foot Locker is a United States retailer of athletic footwear, apparel, and accessories for active women. Its stores carry athletic footwear and apparel brands, as well as casual wear and an assortment of apparel designed for a variety of activities, including running, walking, training, and fitness. In November 2012, the Company announced the introduction of a new banner named SIX:02. This new banner is an elevated retail concept featuring brand! s in fitness apparel and athletic footwear for women. Lady Foot Locker and SIX:02 operate 300 and 3 stores, and are located in the United States, Puerto Rico, and the United States Virgin Islands. These stores have an average of 1,300 selling square feet.
The Company�� Kids Foot Locker is a national children�� athletic retailer that offers a selection of brand-name athletic footwear, apparel and accessories for children. Its stores feature an environment geared to appeal to both parents and children. Its 305 stores are located in the United States, Puerto Rico, the United States Virgin Islands, Europe, and Canada. These stores have an average of 1,400 selling square feet. Footaction is a national athletic footwear and apparel retailer. Its 283 stores are located throughout the United States and Puerto Rico and focus on marquee footwear and branded apparel. The Footaction stores have an average of 2,900 selling square feet. Champs Sports is a mall-based specialty athletic footwear and apparel retailers in North America. Its product categories include athletic footwear and apparel, and sport-lifestyle inspired accessories. Its 539 stores are located throughout the United States, Canada, Puerto Rico, and the United States Virgin Islands. The Champs Sports stores have an average of 3,500 selling square feet. As of February 2, 2013, the Company operated 22 stores in the United States.
Direct-to-Customers
The Company�� Direct-to-Customers segment is multi-branded and multi-channeled. This segment sells, through its affiliates, directly to customers through its Internet websites, mobile devices, and catalogs. The Direct-to-Customers segment operates the Websites for eastbay.com, final-score.com, eastbayteamservices.com, ccs.com, as well as Websites aligned with the brand names of its store banners (footlocker.com, ladyfootlocker.com, kidsfootlocker.com, footaction.com, and champssports.com). Eastbay is a direct marketer in the United States, providing the high sch! ool athle! te with a sports solution, including athletic footwear, apparel, equipment, team licensed, and private-label merchandise. CCS serves the needs of the 12-20 year old seeking an authentic board lifestyle shop. CCS is anchored in skate but appealing to the surrounding board culture. The CCS format offers board lifestyle merchandise that will fit the needs of the customer all year long and stocks a selection of both core and lifestyle brands. The retail store operations of CCS are included in the Athletic Stores segment.
Advisors' Opinion:- [By Jake L'Ecuyer]
Foot Locker (NYSE: FL) was also up, gaining 8.07 percent to $46.19 as the company announced better-than-expected Q4 results.
Equities Trading DOWN
Shares of Analogic (NASDAQ: ALOG) were down 16.00 percent to $80.11 after the company reported downbeat Q2 earnings. CJS Securities downgraded the stock from Market Outperform to Market Perform and cut the price target from $97.00 to $90.00. - [By Saumya Vaishampayan and Ben Eisen]
Foot Locker Inc. (FL) �shares rose 4.1%. The retailer said strong top-line sales growth pushed up per-share earnings to 70 cents a share in the third quarter. Adjusted profit was also up at 68 cents a share, beating analyst estimates of 66 cents, according to a FactSet survey.
- [By Rich Smith]
New York City-based Foot Locker (NYSE: FL ) is buying itself a subsidiary in Germany.
The footwear and sportswear purveyor, which already has a presence in the country (and 22 other countries besides) announced Wednesday that it has signed a definitive agreement to acquire Runners Point Warenhandelsges, or RPG, from its majority owner, private equity firm Hannover Finanz, and its minority owners, Chief Executive Office Otto Hurler and Chief Financial Officer Harald Wittig, for a total of $94 million cash.
- [By Lee Jackson]
Consumer Discretionary: Foot Locker Inc. (NYSE: FL) offers an attractive risk/reward at its current level, with a solid road map to mid-single-digit comparisons and very solid mid-teens earnings per share (EPS) growth. The great thing for investors is that gym shoes wear out and are expensive. Credit Suisse has a $43 price target, and the consensus target is $39. Investors are paid a 2.3% dividend. A move to the Credit Suisse target would be a 26% gain for investors. The stock closed Tuesday at $34.01
Top Life Sciences Stocks To Own For 2014: SPDR S&P Midcap 400 ETF (MDY)
MidCap SPDRS, Standard & Poor's Depository Receipts, represent ownership interests in the MidCap SPDR Trust, Series 1 (the Trust), which is a unit investment trust that seeks to match the total return of the Standard & Poor's Midcap 400 Composite Price Index (the S&P MidCap Index). To accomplish this, the Trust utilizes a full replication approach.
The Trust's holdings comprise 400 stocks in the S&P MidCap 400 Index, which is designed to capture the price performance of the middle capitalization segment of the United States publicly traded stock market. All 400 securities of the S&P MidCap 400 Index are owned by the Trust in their approximate market capitalization weight.
Advisors' Opinion:- [By BENZINGA]
So, for those who pay attention to such things, imagine the excitement coming into Monday's session as the DJIA was flirting with 16,000, the S&P 500 (NYSE: SPY) was closing in on 1,800, the NASDAQ (NYSE: QQQ) was flirting with 4,000 (something it hasn't done in at least a decade) and while, considerably less important, the S&P Midcap (NYSE: MDY) was just above 1,300. In short, if a big, round number is important, then four of them must be monumental, right?
Top Life Sciences Stocks To Own For 2014: Acorda Therapeutics Inc.(ACOR)
Acorda Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the identification, development, and commercialization of novel therapies for multiple sclerosis (MS), spinal cord injury (SCI), and other central nervous system disorders primarily in the United States. Its marketed products include Ampyra (dalfampridine), a potassium channel blocker for improving walking in patients with MS; and Zanaflex Capsules and Zanaflex tablets (tizanidine hydrochloride), a short-acting drug for the management of spasticity. The company also markets products for the improvement of walking in adult patients with MS with walking disability under the Fampyra name internationally. Its lead research and development programs include three biologic therapeutic approaches for restoring neurologic and cardiac function, which comprise Neuregulin Program for developing Glial Growth Factor 2, a molecule in the Phase I clinical trial for the treatment of heart failure; Remyelina ting Antibodies Program for developing rHIgM22, an antibody in the preclinical stage for treating MS; and Chondroitinase Program, a research stage program focused on developing chontroitinase as a therapeutic to break down inhibitory factors in the scar tissue that develops as a result of an injury to the CNS. In addition, the company has in-licensed a clinical-stage program, AC105, to develop an acute treatment for neurological trauma. It has collaboration agreement with Biogen Idec International GmbH to develop and commercialize products containing aminopyridines to the treatment of MS. Acorda Therapeutics, Inc. was incorporated in 1995 and is headquartered in Hawthorne, New York.
Advisors' Opinion:- [By Sean Williams]
What: Shares of Acorda Therapeutics (NASDAQ: ACOR ) , a commercial-stage biopharmaceutical company with a focus on central nervous system disorders, jumped as much as 13% after the company reported positive phase 2 trial data for experimental drug Ampyra for the treatment of post-stroke deficits.
Top Life Sciences Stocks To Own For 2014: MGT Capital Investments Inc (MGT)
MGT Capital Investments, Inc (MGT), incorporated in 1977, is a holding company. As of December 31, 2011, the Company was analyzing potential acquisition opportunities in healthcare marketing and technology, as well as various intellectual property assets. The Company has a controlling interest in Medicsight ltd (Medicsight) and its subsidiaries Medicsight, Inc., Medicsight KK (Japan), Medicsight Pty Limited (Australia), Medicsight FZE (UAE), MedicEndo Limited (UAE), MedicCO2lon Limited (UAE) and Medicsight UK Limited (UK). The Company also have wholly owned subsidiaries MGT Capital Investments (UK) Limited, MGT Investments (Gibraltar) Limited, and Medicsight. Medicsight and its wholly owned subsidiaries is a medical technology company focusing on medical imaging software development and medical hardware devices. On March 29, 2011 the Company disposed of its 49% holding in Moneygate Group Limited (Moneygate). In September 2013, MGT Capital Investments, Inc MGT Interactive, LLC acquired certain assets from Gioia Systems LLC.
Medicsight�� core technology is the ColonCAD algorithm that is integrated (using application protocol interface (API) technology) into visualization workstations for radiologists to use when reviewing a patient�� colon computer tomography (CT) scan data. The computer-aided detection (CAD) algorithm assists the radiologist as they search for polyps in the CT scan image data. The radiologist uses the visualization software to review the patient�� CT scan images on the screen and searches for polyps (potentially pre-cancerous lesions on the wall of the colon). After a full review, the radiologist then activates the Medicsight ColonCAD software, which immediately displays CAD marks on the images, drawing the radiologist�� attention to potential polyps and other regions of interest. The radiologist then assesses each marked region in order to make the final decision as to the presence or absence of a polyp.
In addition to the computer aided detection so! ftware applications, Medicsight has developed an automated carbon dioxide (CO2) insufflation device, MedicCO2LON. A patient undergoing a CT colon scan requires the colon to be insufflated (distended) with either CO2 gas or room air administered prior to the acquisition of their CT colonography images. MedicCO2LON is designed to provide insufflation, for the acquisition of images from the CT colonography examination.
The Company competes with GE, Hitachi, Philips, Siemens and Toshiba.
Advisors' Opinion:- [By Markman Advisors]
Public companies leveraging their patent portfolios, (aka "patent plays"), are getting the market's attention. Companies such as Vringo (VRNG), ParkerVision (PRKR), MGT Capital (MGT), Worlds Inc. (WDDD.OB) and others have presented trading opportunities due to their volatility while retaining the chance for a big payoff to those investors who stay the course. Yet there exist viable patent plays that are still undiscovered. Some of these so called "plays," which are not getting enough attention, are actually real companies making and selling real products or services in contrast to pure patent monetization companies. Some known examples are Single Touch Interactive (SITO.OB) and Blue Calypso (BCYP.OB). This article is focused on another one of these patent plays, On Track Innovations Ltd. (OTIV).
No comments:
Post a Comment